Ryan Philip E, Davies Gareth C, Nau Marion M, Lipkowitz Stanley
Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Trends Biochem Sci. 2006 Feb;31(2):79-88. doi: 10.1016/j.tibs.2005.12.004. Epub 2006 Jan 6.
Cbl proteins are regulators of signal transduction through many pathways and, consequently, regulate cell function and development. They are ubiquitin ligases that ubiquitinate and target many signaling molecules for degradation. The Cbl proteins themselves are regulated by an increasingly complex network of interactions that fine-tune the effects that Cbl proteins have on signaling. The negative regulation of Cbl protein function can occur via cis-acting structural elements that prevent inappropriate ubiquitin ligase activity, degradation of the Cbl proteins, inhibition without degradation owing to interaction with other signaling proteins, deubiquitination of Cbl substrates, and regulation of assembly of the endosomal ESCRT-I complex. Defects in the regulatory mechanisms that control Cbl function are implicated in the development of immunological and malignant diseases.
Cbl蛋白是多种信号转导途径的调节因子,因此可调节细胞功能和发育。它们是泛素连接酶,可将许多信号分子泛素化并使其靶向降解。Cbl蛋白自身受一个日益复杂的相互作用网络调节,该网络可微调Cbl蛋白对信号转导的影响。Cbl蛋白功能的负调控可通过以下方式发生:顺式作用结构元件阻止不适当的泛素连接酶活性、Cbl蛋白的降解、与其他信号蛋白相互作用导致的不降解抑制、Cbl底物的去泛素化以及内体ESCRT-I复合物组装的调节。控制Cbl功能的调节机制缺陷与免疫和恶性疾病的发生有关。